1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Molecular Diagnostics Market: By Products (Analyzers, Reagents) Technology (PCR, INAAT, Hybridization, DNA Sequencing Others) End Users (Hospitals, Clinical Laboratories, Academics) Applications (Oncology, Microbiology, Others)-Forecast(2015-2020)

Molecular Diagnostics is a diasnosis technique that utilizes DNA, RNA and proteins to detect specific health condition or diseases. Molecular Diagnostics represents enormous market growth of in-vitro diagnostics and now-a-days routinely used in hospitals, reference labs, and blood banks.

This report gives an in-depth segmentation of the market by products, technology and applications. It also segmented by end user verticals and key geographic regions like Americas, Europe and Asia-pacific. Cost analysis, pricing analysis and the overall competitive landscape of key players are also analyzed in great detail in the report.

Competitive landscape for each of the product types is highlighted and market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2014 are provided.

The prominent players profiled in this report are:
Abbott Diagnostics
Beckman Coulter
Becton
Dickinson & Co
Biomérieux.
The report contains the most detailed and in-depth segmentation of the global Molecular Diagnostics market.

Table Of Contents

Molecular Diagnostics Market: By Products (Analyzers, Reagents) Technology (PCR, INAAT, Hybridization, DNA Sequencing Others) End Users (Hospitals, Clinical Laboratories, Academics) Applications (Oncology, Microbiology, Others)-Forecast(2015-2020)
1. Molecular Diagnostics Market - Market Overview
2. Executive Summary
3. Molecular Diagnostics Market - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis
4. Molecular Diagnostics Market - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Molecular Diagnostics Market - Government Regulations
6. Molecular Diagnostics Market - Strategic Analysis
6.1. Value Chain Analysis
6.2. Pricing Analysis
6.3. Opportunities Analysis
6.4. Product/Market Life Cycle Analysis
7. Molecular Diagnostics Market - By Products
7.1. Analyzers
7.2. Reagents
8. Molecular Diagnostics Market - By Technology
8.1. PCR
8.2. INAAT
8.3. Hybridization
8.4. DNA Sequencing and Next Generation Sequencing
8.5. Microarray
8.6. Spectral Karyotype Imaging (SKI)
8.7. Others
9. Molecular Diagnostics Market - By End Users
9.1. Hospitals
9.2. Clinical Laboratories
9.3. Academics
10. Molecular Diagnostics Market - By Applications
10.1. Infectious Disease
10.1.1. HBV
10.1.2. HCV
10.1.3. HIV
10.1.4. TB
10.1.5. CT/NG
10.1.6. HPV
10.1.7. MRSA
10.1.8. Others
10.2. Oncology
10.2.1. Prostate Cancer
10.2.2. Breast Cancer
10.2.3. Colorectal Cancer
10.2.4. Others
10.3. Genetic Disease Screening
10.4. Blood Screening
10.5. Microbiology
10.6. Others
11. Molecular Diagnostics Market - Geographic Analysis
11.1. Americas
11.2. Europe
11.3. APAC
11.4. ROW
12. Market Entropy
12.1. New Product Launches
12.2. MandAs, Collaborations, JVs and Partnerships
13. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio)
13.1. Abbott Diagnostics, Inc.
13.2. Beckman Coulter, Inc.
13.3. Becton, Dickinson and Co.
13.4. Biomerieux
13.5. Cepheid, Inc.
13.6. Gen-Probe, Inc. (Hologic, Inc.)
13.7. Novartis AG
13.8. Qiagen N.V.
13.9. F. Hoffmann-La Roche Ltd.
13.10. Siemens Healthcare
13.11. Myriad Genetics, Inc.
13.12. Danaher Corporation
13.13. Bio-Rad Laboratories, Inc.
13.14. Quest Diagnostics, Inc.
13.15. Thermo Fisher Scientific
13.16. Johnson and Johnson
13.17. Sysmex
13.18. Bayer Healthcare AG
13.19. Alere Inc.
13.20. Leica Biosystems
13.21. Agilient Technologies, Inc
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
14. Appendix
14.1. Abbreviations
14.2. Sources
14.3. Research Methodology
14.4. Bibliography
14.5. Compilation of Expert Insights
14.6. Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...


Download Unlimited Documents from Trusted Public Sources

Diagnostics Industry in the UK

  • October 2016
    10 pages
  • Diagnostics  

  • United Kingdom  

View report >

Diagnostics Industry in the UK

  • October 2016
    10 pages
  • Diagnostics  

  • United Kingdom  

View report >

Biopsy Industry in the US

  • October 2016
    7 pages
  • Biopsy  

    Magnetic Resona...  

    Cancer  

  • United States  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.